Three more biotechs hit Nasdaq as the sector, now with more than $13B raised, continues barreling toward record

Editor’s note: Interested in following biopharma’s fast-paced IPO market? You can bookmark our IPO Tracker here.

After a summer slumber, the biotech IPO market is back in full swing with three new pricings dropping Wednesday and two SPACs entering the ring.

DiCE Therapeutics and Tyra Biosciences each hit Nasdaq...

Click to view original post